PARK DENTAL PARTNERS INC (PARK)
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-11-04
$21.34+5.15%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-11-04
QuarterlyIQ Insights · PARK
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
No current thesis-health read is available for this company.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -4.0% |
| Our one-year growth estimate | diamond | Not available |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 13 industry peers
PARK — capital allocation — Unregistered Sales of Equity Securities
Dated 2026-08-10
Unregistered Sales of Equity Securities. The information set forth in
Why it matters: Q2 revenue grew 5.1%, but same-practice growth slowed to 2.3%. The Q3 result tests whether growth holds.
Worry ifOn November 12, Q3 revenue is below $64 million. That is near Q2 revenue of $66.2 million after normal seasonal changes.
Less concerning ifOn November 12, Q3 revenue is at least $66.2 million and same-practice growth is above 2.3%.
Why it matters: The company raised its revenue outlook after the first half. That range assumes 3.5% to 5.0% organic growth and steady patient demand.
Watch forFull-year 2026 revenue is at least $256 million and no more than $260 million.
Also watch forThe company cuts the 2026 revenue range below $256 million or reports full-year revenue below that level.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$190 on $10,000 · ±1.9% | How much price usually moves either way. |
| Bad day | $585 loss on $10,000 · 5.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,328 loss on $10,000 · 23.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.